Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18439987 | PRODUCTION OF RETINOL | February 2024 | October 2025 | Abandon | 20 | 0 | 1 | No | No |
| 18512389 | BACTERIA FOR THE TREATMENT OF DISORDERS | November 2023 | October 2025 | Allow | 23 | 1 | 0 | No | No |
| 18507533 | CENTRIFUGATION AND FILTRATION METHODS FOR CONCENTRATING MICROORGANISMS | November 2023 | September 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18174165 | TCRa HOMING ENDONUCLEASE VARIANTS | February 2023 | November 2024 | Allow | 21 | 2 | 0 | No | Yes |
| 18150905 | MICROBIAL POLYSACCHARIDES AND METHODS OF USE | January 2023 | June 2025 | Abandon | 29 | 2 | 1 | No | No |
| 17938238 | PREPARATION METHOD AND APPLICATION OF ION-ACTIVATED BIOADHESIVE HYDROGEL | October 2022 | May 2024 | Abandon | 19 | 2 | 1 | Yes | No |
| 17789058 | COMPOSITION FOR PRODUCING CERAMIDE | September 2022 | November 2025 | Allow | 41 | 1 | 0 | Yes | No |
| 17818240 | STRAIN OF ENTEROBACTER FOR DEGRADING HYALURONIC ACID AND APPLICATION THEREOF | August 2022 | July 2023 | Allow | 11 | 1 | 0 | No | No |
| 17783595 | Improved Aminopeptidases for Single Molecule Peptide Sequencing | June 2022 | August 2025 | Abandon | 38 | 1 | 1 | No | No |
| 17623166 | SELF-ASSEMBLED CATALASE NANOPARTICLE AND PREPARATION METHOD THEREFOR AND USE THEREOF | January 2022 | May 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17626877 | MODIFIED TRICHODERMA FUNGAL STRAIN FOR THE PRODUCTION OF AN ENZYME COCKTAIL | January 2022 | December 2025 | Allow | 47 | 4 | 0 | No | No |
| 17616156 | NOVEL LACTIC ACID BACTERIA STRAIN - ANTIBACTERIAL PEPTIDES PRODUCED BY SAID STRAIN AND RELATED PHARMACEUTICAL COMPOSITIONS | December 2021 | February 2026 | Allow | 50 | 2 | 1 | No | No |
| 17613973 | ANTIBACTERIAL COMPOSITION | November 2021 | May 2025 | Abandon | 42 | 1 | 1 | No | No |
| 17609269 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | November 2021 | July 2025 | Allow | 45 | 1 | 1 | No | No |
| 17504852 | PENICILLIN-G ACYLASES | October 2021 | March 2025 | Allow | 41 | 3 | 1 | No | No |
| 17602180 | ANTIMICROBIAL COMPOSITION FOR SELECTIVE LYSIS OF S. HOMINIS BACTERIA | October 2021 | September 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17440182 | FAECALIBACTERIUM SP. MICROBE AND ANTICANCER COMPOSITION COMPRISING SAME | September 2021 | November 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17432046 | CHEMICAL SCALPEL | August 2021 | September 2025 | Abandon | 49 | 2 | 1 | No | No |
| 17427587 | STALL SIDE METHOD FOR THE DETECTION OF BACTERIA IN DAIRY CATTLE | July 2021 | January 2024 | Abandon | 30 | 1 | 0 | No | No |
| 17425885 | METHOD FOR PROCESSING AND ANALYSIS OF VISCOUS LIQUID BIOLOGICAL SAMPLES | July 2021 | September 2024 | Abandon | 38 | 2 | 0 | No | No |
| 17362562 | SYSTEMS AND METHODS FOR PRODUCING POLYHYDROXYALKANOATES FROM ORGANIC WASTE | June 2021 | June 2025 | Abandon | 47 | 4 | 0 | No | No |
| 17418005 | HOLDERMANELLA SP. BACTERIUM AND USE THEREOF | June 2021 | November 2024 | Allow | 41 | 4 | 0 | Yes | No |
| 17416692 | NOVEL DOLOSIGRANULUM PIGRUM STRAINS AND USES THEREOF | June 2021 | July 2025 | Allow | 49 | 2 | 1 | No | No |
| 17416134 | SPIRAMYCIN-PRODUCING STRAIN, CARRIMYCIN-PRODUCING STRAIN, CONSTRUCTION METHOD THEREFOR, USE THEREOF AND METHOD FOR INCREASING PRODUCT YIELD THEREOF | June 2021 | March 2024 | Abandon | 33 | 0 | 1 | No | No |
| 17312698 | PHARMACEUTICAL COMPOSITION COMPRISING LACTOBACILLUS SAKEI WIKIM30 AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | June 2021 | August 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17298464 | SCALABLE BIOSYNTHESIS OF THE SEAWEED NEUROCHEMICAL KAINIC ACID | May 2021 | March 2025 | Allow | 46 | 0 | 1 | Yes | No |
| 17245052 | Detection of waterborne pathogens with paper strips | April 2021 | January 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17054433 | NOVEL STRAINS HAVING EFFECTS OF PREVENTING OR TREATING CANCERS | April 2021 | November 2025 | Allow | 60 | 3 | 0 | Yes | No |
| 17275337 | CARRIER FOR ENZYME IMMOBILIZATION USE, AND IMMOBILIZED ENZYME | March 2021 | February 2024 | Abandon | 35 | 3 | 1 | Yes | No |
| 17274164 | PRINTABLE MAGNETIC POWDERS AND 3D PRINTED OBJECTS FOR BIONANOCATALYST IMMOBILIZATION | March 2021 | August 2025 | Abandon | 54 | 4 | 1 | No | No |
| 17263507 | RECOMBINANT YEAST STRAIN HAVING STEROL PRODUCTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF | February 2021 | August 2025 | Allow | 55 | 2 | 1 | No | No |
| 17270661 | C4-DICARBOXYLIC ACID TRANSPORTER FOR INCREASING OIL YIELD OF MUCOR CIRCINELLOIDES | February 2021 | December 2024 | Abandon | 45 | 1 | 1 | No | No |
| 17263685 | MUTANT OF TRICHODERMA FILAMENTOUS FUNGUS AND METHOD OF PRODUCING PROTEIN | January 2021 | April 2024 | Allow | 39 | 6 | 0 | Yes | No |
| 17153702 | METHOD FOR PRODUCING FUNCTIONAL SUBSTANCE | January 2021 | March 2025 | Allow | 50 | 4 | 1 | Yes | No |
| 17261454 | MATERIALS AND METHODS FOR CREATING STRAINS OF SACCHAROMYCES CEREVISIAE THAT EXHIBIT AN INCREASED ABILITY TO FERMENT OLIGOSACCHARIDES INTO ETHANOL | January 2021 | August 2024 | Allow | 43 | 1 | 0 | No | No |
| 17257168 | POLYPEPTIDES AND COMPOSITIONS WITH LYTIC POLYSACCHARIDE OXIDASE ACTIVITY | December 2020 | December 2024 | Abandon | 47 | 0 | 1 | No | No |
| 17134296 | ENTEROBACTER AND ITS APPLICATION | December 2020 | November 2022 | Abandon | 23 | 2 | 1 | Yes | No |
| 17255507 | METHOD OF ENRICHMENT OF MICRO-ORGANISMS IN WHOLE BLOOD | December 2020 | September 2022 | Abandon | 21 | 0 | 1 | No | No |
| 17131293 | YEAST EXPRESSING CELLULASES FOR SIMULTANEOUS SACCHARIFICATION AND FERMENTATION USING CELLULOSE | December 2020 | September 2025 | Abandon | 57 | 3 | 0 | No | No |
| 17251745 | METHODS OF MEASURING ENZYME ACTIVITY IN COATING COMPOSTIONS | December 2020 | August 2025 | Abandon | 57 | 4 | 0 | No | No |
| 17251492 | METHOD FOR DETECTING SYNOVIAL JOINT INFECTIONS | December 2020 | September 2023 | Abandon | 34 | 2 | 0 | Yes | No |
| 15734909 | LACTOBACILLUS REUTERI LM1071 FROM BREAST MILK HAVING HIGH SAFETY AND INTESTINE ADHESIVE PROPERTY, AND COMPOSITION COMPRISING THE STRAIN OR ITS CULTURE FLUID | December 2020 | May 2025 | Abandon | 53 | 7 | 0 | Yes | No |
| 17057680 | RECOMBINANT LYSINS | November 2020 | May 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17100496 | CARBOHYDRATE ESTERS AS INDUCERS FOR GENE EXPRESSION | November 2020 | June 2024 | Abandon | 43 | 3 | 1 | No | No |
| 17094994 | CONJUGATES OF FATTY ACID-THERAPEUTIC PROTEINS FOR HALF-LIFE EXTENSION AND USE OF THE SAME | November 2020 | November 2024 | Abandon | 48 | 4 | 1 | Yes | No |
| 17054225 | A METHOD OF STRAIN DEVELOPMENT | November 2020 | June 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17090092 | CENTRIFUGATION AND FILTRATION METHODS FOR CONCENTRATING MICROORGANISMS | November 2020 | December 2023 | Abandon | 37 | 1 | 0 | No | No |
| 17070922 | ACIDITY NEUTRALIZING COMPOSITION | October 2020 | September 2022 | Abandon | 23 | 1 | 0 | No | No |
| 17064826 | INDIGENOUS AND IMPROVED FUNGALLY FERMENTED CBD, CBG AND RELATED CANNABINOID ORAL DOSAGE FORMS | October 2020 | December 2023 | Abandon | 38 | 5 | 1 | Yes | No |
| 16980042 | STREPTOMYCES COELICOLOR MUTANT STRAIN, METHOD OF PRODUCING BETA-AGARASE BY USING SAME, AND METHOD OF PRODUCING NEOAGARO-OLIGOSACCHARIDES BY USING SAME | September 2020 | June 2022 | Allow | 21 | 1 | 1 | No | No |
| 17003659 | SYSTEM AND METHOD OF INDUCIBLY CLUSTERING METABOLIC ENZYMES FOR THE PRODUCTION OF CHEMICALS USING CELL FACTORIES | August 2020 | June 2025 | Abandon | 58 | 4 | 1 | No | No |
| 16975681 | NOVEL ENZYME AND METHOD FOR ASSAYING PENTOSIDINE USING SAME | August 2020 | December 2023 | Allow | 40 | 2 | 0 | Yes | No |
| 16983335 | METHOD OF PROMOTING BONE REGROWTH | August 2020 | August 2022 | Allow | 25 | 0 | 0 | Yes | No |
| 16964994 | Materials and Methods for Producing Cardiolipin-Like Phospholipids | July 2020 | October 2022 | Abandon | 26 | 0 | 1 | No | No |
| 16956435 | METHODS AND KITS FOR QUANTIFYING ADENOSINE-CONTAINING MOLECULES | June 2020 | February 2024 | Allow | 44 | 2 | 1 | Yes | No |
| 16878309 | KIT AND METHOD FOR ANTIBIOTICS SUSCEPTIBILITY TESTING WITH THE AGAR DILUTION METHOD | May 2020 | September 2023 | Abandon | 40 | 1 | 1 | No | No |
| 15930697 | TEXTILE COMPRISING SILANIZED SYMBIOTIC CULTURE OF BACTERIA AND YEAST | May 2020 | April 2024 | Abandon | 47 | 0 | 1 | No | No |
| 16758989 | ACHROMOBACTER XYLOSOXIDANS WITH MONOMETHYLAMINE DEGRADABILITY AND APPLICATION THEREOF | April 2020 | November 2023 | Abandon | 43 | 3 | 0 | No | No |
| 16759304 | AMPLIFICATION NANOSWITCH SYSTEM BASED ON SPLIT SITE-SPECIFIC CLEAVING ENZYMES FOR THE IN VITRO DETECTION OF TARGET ANALYTES AND METHOD FOR THE DETECTION OF SAID TARGET ANALYTES | April 2020 | December 2023 | Abandon | 43 | 1 | 1 | No | No |
| 16854608 | MICRO-ORGANOIDS, AND METHODS OF MAKING AND USING THE SAME | April 2020 | November 2023 | Abandon | 43 | 2 | 0 | No | No |
| 16842923 | MICROBIAL POLYSACCHARIDES AND METHODS OF USE | April 2020 | May 2023 | Abandon | 37 | 2 | 1 | No | No |
| 16648851 | PRODUCTION OF RETINOL | March 2020 | March 2024 | Abandon | 48 | 2 | 1 | No | Yes |
| 16812967 | FERMENTATION PROCESS FOR THE PRODUCTION OF LIPIDS | March 2020 | November 2024 | Abandon | 57 | 5 | 0 | No | No |
| 16642918 | Method and device of using aqueous two-phase systems (ATPS) for enhancing diagnostics for dental and oral diseases | February 2020 | July 2024 | Abandon | 52 | 4 | 1 | Yes | No |
| 16641526 | SURFACE ACOUSTIC WAVE (SAW) 3D PRINTING METHOD | February 2020 | September 2023 | Abandon | 43 | 2 | 0 | No | No |
| 16749977 | Immobilized enzyme Pickering emulsion reaction system and application thereof | January 2020 | December 2023 | Abandon | 47 | 3 | 0 | No | No |
| 16627229 | LABEL FREE DETECTION OF PROTEASE ACTIVITY | December 2019 | September 2022 | Abandon | 32 | 0 | 1 | No | No |
| 16623578 | Enzyme Slurry Composition | December 2019 | May 2024 | Abandon | 53 | 5 | 0 | No | Yes |
| 16621792 | BACTERIA FOR THE TREATMENT OF DISORDERS | December 2019 | October 2023 | Allow | 46 | 2 | 1 | Yes | No |
| 16689793 | SYSTEMS AND METHODS USING BACTERIOPHAGE-MEDIATED LYSIS FOR DETECTION AND IDENTIFICATION OF MICROORGANISMS IN A FLUID SAMPLE | November 2019 | August 2025 | Abandon | 60 | 4 | 1 | No | Yes |
| 16677198 | DEGRADATION OF LIGNOCELLULOSIC MATERIAL | November 2019 | September 2025 | Abandon | 60 | 6 | 1 | No | No |
| 16667086 | CELL LYSIS AND BIOMOLECULE DISASSOCIATION SYSTEM AND METHOD FOR MASS SPECTROMETRY OR OTHER ANALYSIS | October 2019 | September 2023 | Abandon | 46 | 2 | 1 | No | No |
| 16573671 | ANTIFUNGAL COMPOSITION AND METHOD OF USE | September 2019 | March 2023 | Abandon | 42 | 2 | 1 | No | No |
| 16528871 | METHOD FOR DETERMINING CAUSE OF THE PROLONGATION OF BLOOD COAGULATION TIME | August 2019 | September 2023 | Abandon | 50 | 3 | 1 | No | No |
| 16503761 | METHODS FOR PREPARATION OF NEO-CARTILAGE CONSTRUCTS | July 2019 | March 2023 | Abandon | 44 | 0 | 1 | No | No |
| 16430266 | APPARATUS, SYSTEMS, AND METHODS FOR PREPARING AN OUTPUT SAMPLE COMPRISING A DEFINED CONCENTRATION OF AN INFECTIOUS AGENT FOR DOWNSTREAM TESTING | June 2019 | May 2025 | Allow | 60 | 6 | 1 | Yes | No |
| 16340257 | TCRa HOMING ENDONUCLEASE VARIANTS | April 2019 | October 2022 | Allow | 43 | 1 | 0 | Yes | No |
| 16375875 | ENHANCED INTERFERENCE MEMBRANE FOR A WORKING ELECTRODE OF A CONTINUOUS BIOLOGICAL SENSOR | April 2019 | September 2023 | Abandon | 54 | 2 | 1 | Yes | No |
| 16330683 | DETERGENT COMPOSITIONS | March 2019 | September 2022 | Abandon | 43 | 1 | 0 | No | No |
| 16206018 | COSMETIC COMPOSITIONS | November 2018 | October 2025 | Allow | 60 | 6 | 1 | Yes | Yes |
| 16305703 | COMPOSITION AND METHOD FOR IMPROVING THE DEVELOPMENT OF PLANTS | November 2018 | May 2024 | Abandon | 60 | 4 | 1 | No | No |
| 16092211 | MAGNETIC MACROPOROUS POLYMERIC HYBRID SCAFFOLDS FOR IMMOBILIZING BIONANOCATALYSTS | October 2018 | July 2025 | Abandon | 60 | 4 | 1 | Yes | Yes |
| 16143050 | METHOD OF PRINTING A TISSUE CONSTRUCT WITH EMBEDDED VASCULATURE | September 2018 | January 2024 | Abandon | 60 | 2 | 1 | No | No |
| 15905373 | DIFFERENTIATION OF HUMAN IPS CELLS TO HUMAN ALVEOLAR TYPE II VIA DEFINITIVE ENDODERM | February 2018 | May 2024 | Abandon | 60 | 6 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MISHRA, DEEPA.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner MISHRA, DEEPA works in Art Unit 1657 and has examined 74 patent applications in our dataset. With an allowance rate of 25.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 44 months.
Examiner MISHRA, DEEPA's allowance rate of 25.7% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by MISHRA, DEEPA receive 2.35 office actions before reaching final disposition. This places the examiner in the 67% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by MISHRA, DEEPA is 44 months. This places the examiner in the 14% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +43.9% benefit to allowance rate for applications examined by MISHRA, DEEPA. This interview benefit is in the 90% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 7.5% of applications are subsequently allowed. This success rate is in the 3% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 17.1% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 52% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 90.9% are granted (fully or in part). This grant rate is in the 88% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.